Jiang J, Jiang L, Maldonato BJ, et al. Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers. Cancer discovery. 2024:OF1-OF24. doi:10.1158/2159-8290.CD-24-0027
Publications
Charpignon ML, Matos J, Nakayama L, et al. Does diversity beget diversity? A scientometric analysis of over 150,000 studies and 49,000 authors published in high-impact medical journals between 2007 and 2022. medRxiv : the preprint server for health sciences. 2024. doi:10.1101/2024.03.21.24304695
Caputo B, De Marco CM, Pichler V, et al. Speciation within the complex: high-throughput whole genome sequencing reveals evidence of a putative new cryptic taxon in ’far-west’ Africa. Research square. 2024. doi:10.21203/rs.3.rs-3914444/v1
Granger SJ, May V, Hammack SE, et al. Circulating PACAP levels are associated with altered imaging measures of entorhinal cortex neurite density in posttraumatic stress disorder. European journal of psychotraumatology. 2024;15(1):2335793. doi:10.1080/20008066.2024.2335793
Granger SJ, May V, Hammack SE, et al. Circulating PACAP levels are associated with altered imaging measures of entorhinal cortex neurite density in posttraumatic stress disorder. European journal of psychotraumatology. 2024;15(1):2335793. doi:10.1080/20008066.2024.2335793
Xiong K, Zhang R, Ma J. scGHOST: identifying single-cell 3D genome subcompartments. Nature methods. 2024. doi:10.1038/s41592-024-02230-9
Mittal K, Cooper GW, Lee BP, et al. Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin. Communications biology. 2024;7(1):426. doi:10.1038/s42003-024-06140-6
Holderfield M, Lee BJ, Jiang J, et al. Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy. Nature. 2024. doi:10.1038/s41586-024-07205-6
Kratchmarov R, Djeddi S, Dunlap G, et al. TCF1-LEF1 co-expression identifies a multipotent progenitor cell (T2-MPP) across human allergic diseases. Nature immunology. 2024. doi:10.1038/s41590-024-01803-2
Prosz A, Sahgal P, Huffman BM, et al. Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting. NPJ precision oncology. 2024;8(1):87. doi:10.1038/s41698-024-00561-6